脾脏是人体重要的免疫器官，随着外科技术的发展，脾部分切除术凭借能够保留脾脏功能的优势，逐渐成为脾脏良性疾病患者手术治疗的首选术式。腹腔镜脾部分切除术（LPS）凭借创伤小、疼痛轻、恢复快、能够保留脾脏功能等优势，成为目前脾脏良性疾病患者手术治疗的主流术式。随着近年来机器人辅助手术系统在医学领域应用的迅速发展，机器人辅助脾部分切除术（RPS）逐渐成为替代LPS的新选择。目前，微创脾部分切除术的适应证不断拓展，手术关键环节的处理不断精进，手术效果和安全性显著提高。随着人工智能（AI）、增强现实（AR）、3D打印等数智化和虚拟现实技术的融入，未来脾脏手术治疗也将向更加个性化、精准化、智能化的方向发展，进一步改善患者预后，提高生活质量。

Spleen is an important immune organ of human body. With the development of surgical technologies, partial splenectomy has gradually become the primary option for patients with benign spleen diseases due to its advantages of preserving spleen function. Laparoscopic partial splenectomy (LPS) has served as the mainstream surgical procedure for patients with benign spleen lesions due to mild trauma, slight pain, rapid recovery and preservation of spleen function, etc. Along with rapid development of robot-assisted surgery system in medical field in recent years, robot-assisted partial splenectomy (RPS) has gradually become a novel alternative to LPS. At present, the indications of minimally invasive partial splenectomy have been constantly expanded, the key surgical procedures have been continually modified, and surgical efficacy and safety have been significantly improved. With the integration of artificial intelligence (AI), augmented reality (AR), 3D printing and other digital intelligence and virtual reality technologies, spleen surgery will develop in a more individualized, precise and intelligent direction in the future, further improving clinical prognosis and quality of life of patients.